161 related articles for article (PubMed ID: 2685357)
1. A highly efficient retroviral vector allows detection of the transforming activity of the human c-fps/fes proto-oncogene.
Feldman RA; Lowy DR; Vass WC; Velu TJ
J Virol; 1989 Dec; 63(12):5469-74. PubMed ID: 2685357
[TBL] [Abstract][Full Text] [Related]
2. Selective potentiation of c-fps/fes transforming activity by a phosphatase inhibitor.
Feldman RA; Lowy DR; Vass WC
Oncogene Res; 1990; 5(3):187-97. PubMed ID: 2157188
[TBL] [Abstract][Full Text] [Related]
3. Human cellular fps/fes cDNA rescued via retroviral shuttle vector encodes myeloid cell NCP92 and has transforming potential.
Feldman RA; Vass WC; Tambourin PE
Oncogene Res; 1987; 1(4):441-58. PubMed ID: 3329718
[TBL] [Abstract][Full Text] [Related]
4. Myeloid expression of the human c-fps/fes proto-oncogene in transgenic mice.
Greer P; Maltby V; Rossant J; Bernstein A; Pawson T
Mol Cell Biol; 1990 Jun; 10(6):2521-7. PubMed ID: 2188092
[TBL] [Abstract][Full Text] [Related]
5. Mutant feline sarcoma proviruses containing the viral oncogene (v-fes) and either feline or murine control elements.
Even J; Anderson SJ; Hampe A; Galibert F; Lowy D; Khoury G; Sherr CJ
J Virol; 1983 Mar; 45(3):1004-16. PubMed ID: 6300443
[TBL] [Abstract][Full Text] [Related]
6. Transforming potential of a human protooncogene (c-fps/fes) locus.
Sodroski JG; Goh WC; Haseltine WA
Proc Natl Acad Sci U S A; 1984 May; 81(10):3039-43. PubMed ID: 6328490
[TBL] [Abstract][Full Text] [Related]
7. Contribution of the gag and pol sequences to the leukemogenicity of Friend murine leukemia virus.
Oliff A; McKinney MD; Agranovsky O
J Virol; 1985 Jun; 54(3):864-8. PubMed ID: 3999195
[TBL] [Abstract][Full Text] [Related]
8. The human c-fps/fes gene product expressed ectopically in rat fibroblasts is nontransforming and has restrained protein-tyrosine kinase activity.
Greer PA; Meckling-Hansen K; Pawson T
Mol Cell Biol; 1988 Feb; 8(2):578-87. PubMed ID: 3352601
[TBL] [Abstract][Full Text] [Related]
9. Transformation of NIH 3T3 cells by overexpression of the normal coding sequence of the rat neu gene.
Di Marco E; Pierce JH; Knicley CL; Di Fiore PP
Mol Cell Biol; 1990 Jun; 10(6):3247-52. PubMed ID: 1971420
[TBL] [Abstract][Full Text] [Related]
10. Substitution of the LTR of Abelson murine leukemia virus does not alter the cell type of virally induced tumors.
Green PL; Kaehler DA; McKearn J; Risser R
Oncogene; 1988 Jun; 2(6):585-92. PubMed ID: 2838788
[TBL] [Abstract][Full Text] [Related]
11. Structure of the feline c-fes/fps proto-oncogene: genesis of a retroviral oncogene.
Roebroek AJ; Schalken JA; Onnekink C; Bloemers HP; Van de Ven WJ
J Virol; 1987 Jun; 61(6):2009-16. PubMed ID: 3553615
[TBL] [Abstract][Full Text] [Related]
12. Subgenomic fragment of molecular cloned Friend murine leukemia virus DNA contains the gene(s) responsible for Friend murine leukemia virus-induced disease.
Oliff A; Linemeyer D; Ruscetti S; Lowe R; Lowy DR; Scolnick E
J Virol; 1980 Sep; 35(3):924-36. PubMed ID: 6252347
[TBL] [Abstract][Full Text] [Related]
13. Transforming activity of the RL-akt gene, a c-akt gene activated by long terminal repeat insertion in murine leukemia RL(male symbol)1 cells.
Tanino M; Matsuo M; Uenaka A; Tsukuda K; Ouchida M; Nakayama E; Shimizu K
Mol Carcinog; 1999 Dec; 26(4):286-97. PubMed ID: 10569805
[TBL] [Abstract][Full Text] [Related]
14. Substitution of murine transthyretin (prealbumin) regulatory sequences into the Moloney murine leukemia virus long terminal repeat yields infectious virus with altered biological properties.
Feuer G; Fan H
J Virol; 1990 Dec; 64(12):6130-40. PubMed ID: 2173784
[TBL] [Abstract][Full Text] [Related]
15. Addition of substitution of simian virus 40 enhancer sequences into the Moloney murine leukemia virus (M-MuLV) long terminal repeat yields infectious M-MuLV with altered biological properties.
Hanecak R; Pattengale PK; Fan H
J Virol; 1988 Jul; 62(7):2427-36. PubMed ID: 2836623
[TBL] [Abstract][Full Text] [Related]
16. Regions of the Moloney murine leukemia virus genome specifically related to induction of promonocytic tumors.
Wolff L; Koller R
J Virol; 1990 Jan; 64(1):155-60. PubMed ID: 2403439
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of a neuropathogenic and nonerythroleukemogenic variant of Friend murine leukemia virus PVC-211.
Masuda M; Remington MP; Hoffman PM; Ruscetti SK
J Virol; 1992 May; 66(5):2798-806. PubMed ID: 1560524
[TBL] [Abstract][Full Text] [Related]
18. Rearrangements and insertions in the Moloney murine leukemia virus long terminal repeat alter biological properties in vivo and in vitro.
Fan H; Mittal S; Chute H; Chao E; Pattengale PK
J Virol; 1986 Oct; 60(1):204-14. PubMed ID: 3747027
[TBL] [Abstract][Full Text] [Related]
19. Differential disease restriction of Moloney and Friend murine leukemia viruses by the mouse Rmcf gene is governed by the viral long terminal repeat.
Brightman BK; Li QX; Trepp DJ; Fan H
J Exp Med; 1991 Aug; 174(2):389-96. PubMed ID: 1856627
[TBL] [Abstract][Full Text] [Related]
20. Escape from in vivo restriction of Moloney mink cell focus-inducing viruses driven by the Mo+PyF101 long terminal repeat (LTR) by LTR alterations.
Brightman BK; Farmer C; Fan H
J Virol; 1993 Dec; 67(12):7140-8. PubMed ID: 8230436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
